Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Roche Holding AG
Roche Holding AG News
Jul 21, 2025 - businesswire.com
Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
Jul 21, 2025 - globenewswire.com
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease
Jul 18, 2025 - businesswire.com
Genentech Provides Update on Supplemental Biologics License Application for Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Jul 15, 2025 - globenewswire.com
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
Roche Holding AG Quantitative Score
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Roche Holding AG Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Roche Holding AG Financials
Table Compare
Compare RHHBY metrics with: | |||
|---|---|---|---|
Earnings & Growth | RHHBY | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | RHHBY | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | RHHBY | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | RHHBY | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Roche Holding AG Income
Roche Holding AG Balance Sheet
Roche Holding AG Cash Flow
Roche Holding AG Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Neutral |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Roche Holding AG Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 5.3335 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-05-14 | 1.38899 | Quarterly |
| 2024-05-03 | 1.3925 | Quarterly |
| 2023-03-27 | 1.287 | Quarterly |
| 2022-03-28 | 1.26496 | Quarterly |
| 2021-03-29 | 1.22055 | Quarterly |
Historical Market Cap
Shares Outstanding
Roche Holding AG Executives
| Name | Role |
|---|---|
| Dr. Severin Schwan Ph.D. | Executive Chairman |
| Dr. Alan Hippe | Chief Financial Officer |
| Dr. Thomas Schinecker | Group Chief Executive Officer |
| Ms. Cristina A. Wilbur | Chief People Officer |
| Ms. Barbara Schadler | Head of Group Communications |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Dr. Severin Schwan Ph.D. | Executive Chairman | 1967 | 8.99M | |
| Dr. Alan Hippe | Chief Financial Officer | 1967 | 4.92M | |
| Dr. Thomas Schinecker | Group Chief Executive Officer | 1975 | 4.63M | |
| Ms. Cristina A. Wilbur | Chief People Officer | Female | 1967 | 3.5M |
| Ms. Barbara Schadler | Head of Group Communications | Female | 1962 | -- |